Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Mar 28, 2018

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

Mar 27, 2018

Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee™, Biosimilar Insulin Glargine

Mar 21, 2018

Mylan to Host Investor Day on April 11, 2018, in New York City

Mar 20, 2018

Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin® Injection

Mar 02, 2018

Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.

Feb 28, 2018

Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics

Feb 28, 2018

Mylan Reports Full Year and Fourth Quarter 2017 Results and Provides 2018 Guidance

Feb 28, 2018

Mylan to Present at Barclays Global Healthcare Conference

Feb 28, 2018

Mylan to Present at Raymond James 39th Annual Institutional Investors Conference

Feb 26, 2018

Mylan Defeats Allergan's Maneuver to Rent Tribal Sovereign Immunity to Avoid Restasis® Patent Challenge

Pagination

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Current page 15
Page 16
Page 17
Page 18
Page 19
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.